CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon to share Octave’s vision of transforming neurodegenerative disease care through precision medicine. Watch Now

Recent Announcements & Press

Octave’s CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon

Octave CEO Doug Biehn on NYSE Floor Talk with Judy Shaw

High Notes: Octave Biosciences’ Protein Panel Predicts MS Trajectory- Inside Precision Medicine

Octave Note

MSMilan2023: Making a Mark at the World’s Largest MS Research Meeting

ACTRIMS Preview: Advancing the Science for Patients with MS

Barriers in MS Treatment Adherence

Media Library

living well

Bridging MS: Connecting You to Resources

living well

MRI in MS: From Pixels to Progress

living well

Multiple Sclerosis in Childhood